On Purpose with Jay Shetty
Also in Health & Fitness
Health & Fitness
The Lancet Haematology in conversation with
by The Lancet Group
Today: #169 in Health & Fitness, India on our combined chart.
Share this ranking
Claiming needs an RSS feed. Contact us.
Chart positions today · India
Not on the United States charts we track today.
Not on the United Kingdom charts we track today.
Not on the Canada charts we track today.
Not on the Australia charts we track today.
Not on the Germany charts we track today.
Not on the Brazil charts we track today.
Not on the Mexico charts we track today.
Not on the New Zealand charts we track today.
Not on the Ireland charts we track today.
Not on the Japan charts we track today.
Not on the Philippines charts we track today.
Not on the South Africa charts we track today.
If you like The Lancet Haematology in conversation…, try…
The Checkup with Doctor Mike
Also in Health & Fitness
Huberman Lab
Also in Health & Fitness
The Lancet Voice
From The Lancet Group
The Health Research Podcast
Similar topics: health and research
blooducation's podcast
Similar topics: haematology and haemolytic
Ranking history · India
History builds daily. We started tracking this show on the Health & Fitness, India chart recently, so the trend line appears after a second day of data.
View as table
| Date | Combined Rank | Apple Podcasts |
|---|---|---|
| Oct 11 | #169 | #169 |
Latest episodes
-
Thalassaemia revisited: from health burden to breakthroughs
October 6, 2026 · 48 minThalassaemia care is advancing fast, from gene therapies to AI diagnostics, but access and prevention still lag behind. Hear from the authors of The Lancet Haematology's "Thalassaemia revisited: from health burden to breakthroughs" Series…
-
Adverse event reporting in haematological malignancies with the authors of our Adverse Events Series
August 27, 2026 · 36 minBlood cancer treatments are advancing fast — but so are their side effects. Hear from the authors of The Lancet Haematology's Adverse Event reporting series on better trial design, patient-centric care, and what part 2 (2026) reveals about…
-
Bethany Samuelson Bannow and Maureen Achebe on classical haematological disease in women
August 6, 2026 · 24 minDr Lan-Lan Smith joined the lead author of our latest Commission Dr Bethany Samuelson Bannow and author Dr Maureen Achebe to discuss classical haematological disease in women with Dr Julia Sandrin Gauer from the Intenational Society on…
-
Fabio Efficace and Alice Di Rocco on patient-reported outcomes following CAR T-cell therapy
July 3, 2026 · 16 minMost previous patient-reported outcome results for CAR T-cell therapy have come from clinical trials testing these treatments, but information on how patients experience this treatment in real-world settings is scarce. Dr Fabio Efficace…
-
Carmelo Gurnari on the development of recommendations from the EBMT Practice Harmonisation and Guidelines Committee
June 4, 2026 · 17 minDr Carmelo Gurnari joins us to discuss the development of recommendations from the EBMT Practice Harmonisation and Guidelines Committee on diagnosis, prevention, treatment, and donor management of donor cell-derived haematological…
Show 7 more episodesShow fewer episodes
-
Penelope Stein on acute prophyria
April 28, 2026 · 16 minDr Penelope Stein joins us to discuss the development of new international guidelines for the diagnosis, management, and treatment of the rare, genetically-linked condition, acute prophyria. Click here to read the full article…
-
Marc Riedl on hereditary angioedema
April 2, 2026 · 18 minProfessor Marc Riedl joins us to discuss two trials testing oral deucrictibant for hereditary angioedema attacks: one testing deucrictibant as on-demand therapy to treat attacks and the other testing deucrictibant for prophylaxis of…
-
Julio Delgado and Valentín Ortiz-Maldonado
March 4, 2026 · 12 minDr Julio Delgado and Dr Valentín Ortiz-Maldonado join us to discuss the results of their phase 2 trial testing varnimcabtagene autoleucel for adults with relapsed or refractory B-cell precursor acute lymphoblastic leukaemia in…
-
Julio Delgado and Valentín Ortiz-Maldonado (Spanish version)
March 4, 2026 · 13 minDr Julio Delgado and Dr Valentín Ortiz-Maldonado join us to discuss the results of their phase 2 trial testing varnimcabtagene autoleucel for adults with relapsed or refractory B-cell precursor acute lymphoblastic leukaemia in…
-
Erica Kaye and Dylan Graetz discuss expert recommendations for the conduct and appraisal of qualitative research in haematology
February 4, 2026 · 20 minDr Erica Kaye and Dr Dylan Graetz join us to discuss the importance of qualitative research and how the whole research ecosystem can incorporate and support this type of research to help set the right research questions, and promote the…
-
Presented at ASH: API-CAT post-hoc analysis on predictors of clinically relevant bleeding during extended anticoagulation for cancer-associated VTE
December 31, 2025 · 10 minProfessor Isabelle Mahé joins us to discuss the results of a post-hoc analysis of the API-CAT trial identifying predictors associated with clinically relevant bleeding during extended anticoagulation for cancer-associated venous…
-
Presented at ASH 2025: EPCORE CLL-1 trial on epcoritamab monotherapy for Richter transformation
December 8, 2025 · 14 minArnon Kater joins Daniela Marin of The Lancet Haematology to discuss the phase 1b/2 EPCORE CLL-1 trial of epcoritamab monotherapy for Richter transformation, which is being presented at ASH 2025. Click here to read the full article…
About the show
Lan-Lan Smith, Editor-in-Chief, Emma Cookson, Deputy Editor, and Daniela Marín, Senior Editor at The Lancet Haematology, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy.A monthly audio companion to the journal, this podcast covers a broad range of topics, from racial and ethnic disparities in leukaemia survival outcomes to resuscitation with blood products compared with saline, the link between mental health and lymphoma to haemolytic disease in newborns, and more.